Articles dans des revues avec comité de lecture (463)
  1. 36. Bouchet, A. M., Lairion, F., Ruysschaert, J. M., & Lensink, M. F. (2012). Oligoarginine vectors for intracellular delivery: role of arginine side-chain orientation in chain length-dependent destabilization of lipid membranes. Chemistry and physics of lipids, 165(1), 89-96. doi:10.1016/j.chemphyslip.2011.11.008
  2. 37. Pabst, G., Lonez, C., Vandenbranden, M., Jestin, J., Radulescu, A., Ruysschaert, J. M., & Gutberlet, T. (2012). Stalk-free membrane fusion of cationic lipids via an interdigitated phase. Soft matter, 8, 3243-3249.
  3. 38. Sarroukh, R., Gasper, R., Cerf, E., Ruysschaert, J. M., Goormaghtigh, E., & Raussens, V. (2012). Deciphering the $beta$-Structure Interconversion of the Alzheimer’s Amyloid-$beta$ Peptide Along Fibrils Formation. Biophysical journal, 102(3), 243a.
  4. 39. Celej, M. S., Sarroukh, R., Goormaghtigh, E., Fidelio, G., Ruysschaert, J. M., & Raussens, V. (2012). Alpha-Synuclein Amyloid Oligomers Exhibit Beta-Sheet Antiparallel Structure as Revealed by FTIR Spectroscopy. Biophysical journal, 102(3), 440a-441a.
  5. 40. Urbina Fernandez, P., Collado, M. I., Alonso, A., Goñi, F. L. M. F., Flores-Díaz, M., Alape-Girón, A., Ruysschaert, J. M., & Lensink, M. (2011). Unexpected wide substrate specificity of C. perfringens α-toxin phospholipase C. Biochimica et biophysica acta, 1808(10), 2618-2627. doi:10.1016/j.bbamem.2011.06.008
  6. 41. Andrade, I. D. S., Vianez-Júnior, J. L., Goulart, C. L., Homblé, F., Ruysschaert, J. M., Almeida von Krüger, W. M., Bisch, P. M., de Souza, W., Mohana-Borges, R., & Motta, M. C. M. (2011). Characterization of a porin channel in the endosymbiont of the trypanosomatid protozoan Crithidia deanei. Microbiology, 157(Pt 10), 2818-2830. doi:10.1099/mic.0.049247-0
  7. 42. Cerf, E., Gustot, A., Goormaghtigh, E., Ruysschaert, J. M., & Raussens, V. (2011). High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease. The FASEB journal, 25(5), 1585-1595. doi:10.1096/fj.10-175976
  8. 43. Bersch, B., Derfoufi, K.-M., De Angelis, F., Auquier, V., Ekendé, E. N., Mergeay, M., Ruysschaert, J. M., & Vandenbussche, G. (2011). Structural and metal binding characterization of the C-terminal metallochaperone domain of membrane fusion protein SilB from Cupriavidus metallidurans CH34. Biochemistry, 50(12), 2194-2204. doi:10.1021/bi200005k
  9. 44. Bruyère, C., Lonez, C., Duray, A., Cludts, S., Ruysschaert, J. M., Saussez, S., Yeaton, P., Kiss, R., & Mijatovic, T. (2011). Considering temozolomide as a novel potential treatment for esophageal cancer. Cancer, 117, 2004-2016. doi:10.1002/cncr.25687
  10. 45. Bruyère, C., Mijatovic, T., Lonez, C., Spiegl-Kreinecker, S., Berger, W., Kast, R. E., Ruysschaert, J. M., Kiss, R., & Lefranc, F. (2011). Temozolomide-induced modification of the CXC chemokine network in experimental gliomas. International journal of oncology, 38(5), 1453-1464. doi:10.3892/ijo.2011.964
  11. 46. Itkin, A., Dupres, V., Dufrêne, Y. F., Bechinger, B., Ruysschaert, J. M., & Raussens, V. (2011). Calcium ions promote formation of amyloid β-peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer's disease. PloS one, 6(3), e18250. doi:10.1371/journal.pone.0018250
  12. 47. Le Calve, B., Rynkowski, M., Le Mercier, M., Bruyère, C., Lonez, C., Gras, T., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Ruysschaert, J. M., Kiss, R., & Lefranc, F. (2010). Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia (New York, N.Y.), 12(9), 727-739. doi:10.1593/neo.10526
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 41 42 43 44 45 46 Suivant >>